Orion Capital Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,000
Closed -$36.7K 566
2025
Q2
$36.7K Hold
6,000
0.01% 275
2025
Q1
$45.7K Hold
6,000
0.02% 250
2024
Q4
$49K Sell
6,000
-5,700
-49% -$44.4K 0.02% 241
2024
Q3
$82.6K Buy
11,700
+3,700
+46% +$24.5K 0.04% 125
2024
Q2
$62.8K Sell
8,000
-6,700
-46% -$47.1K 0.03% 201
2024
Q1
$116K Hold
14,700
0.06% 151
2023
Q4
$125K Sell
14,700
-1,200
-8% -$8.79K 0.07% 150
2023
Q3
$121K Hold
15,900
0.08% 146
2023
Q2
$105K Sell
15,900
-2,000
-11% -$10.2K 0.07% 125
2023
Q1
$61K Hold
17,900
0.04% 200
2022
Q4
$49.8K Sell
17,900
-11,000
-38% -$32.9K 0.04% 203
2022
Q3
$83K Hold
28,900
0.07% 157
2022
Q2
$100K Sell
28,900
-5,000
-15% -$19.6K 0.08% 150
2022
Q1
$160K Hold
33,900
0.1% 133
2021
Q4
$205K Sell
33,900
-12,000
-26% -$83.3K 0.12% 117
2021
Q3
$333K Hold
45,900
0.2% 84
2021
Q2
$574K Hold
45,900
0.36% 62
2021
Q1
$473K Buy
45,900
+24,200
+112% +$234K 0.33% 67
2020
Q4
$124K Buy
+21,700
New +$156K 0.09% 114

Other funds holding MDXG

Orion Capital Management's MDXG Position: Q3 2025 in Review

Orion Capital Management sold out of MiMedx Group (MDXG) in Q3 2025, closing a stake of 6,000 shares — an estimated $36.7K sold.

Orion Capital Management first reported a position in MDXG in Q4 2020 and held it in 19 quarters. The position peaked at $574K in Q2 2021. 231 funds tracked by Wall St. Rank hold MDXG as of Q3 2025.

  • Orion Capital Management reported no remaining MiMedx Group position as of Q3 2025 after selling out during the quarter.
  • Orion Capital Management sold 6,000 MiMedx Group shares in Q3 2025, an estimated $36.7K.
  • Orion Capital Management first reported a position in MiMedx Group in Q4 2020 and held it in 19 quarters.
  • Orion Capital Management's MiMedx Group position peaked at $574K in Q2 2021.
  • 231 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2025.

Based on Orion Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.